Indication

Hypoalbuminemia

Hypoalbuminemia is a clinical state and laboratory finding defined by abnormally low circulating levels of serum albumin, typically below 3.5 g/dL, affecting the cardiovascular and extracellular fluid compartments. Read more about Hypoalbuminemia

40 drugs 13 manufacturers

Advertisement

Drugs that treat it

Common Hypoalbuminemia therapies.

Showing 37–40 of 40 drugs

Filter & compare in the drug finder →Opens the drug finder with Hypoalbuminemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hypoalbuminemia.

Hypoalbuminemia is a clinical state and laboratory finding defined by abnormally low circulating levels of serum albumin, typically below 3.5 g/dL, affecting the cardiovascular and extracellular fluid compartments.

It most frequently arises from systemic inflammation, critical illness, severe hepatic dysfunction leading to decreased synthesis, or excessive protein wasting via nephrotic syndrome, protein-losing enteropathy, or extensive burns.

Pathophysiologically, the reduction in serum albumin diminishes intravascular colloid oncotic pressure and alters vascular permeability, predisposing patients to interstitial fluid extravasation, peripheral edema, ascites, and impaired transport of endogenous molecules and drugs.

Personalize your experience

Follow Hypoalbuminemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it